Clinical Trial Update: Immunobiology of Cancer

View source ↗

Summary

This is a clinical trial update from Stanford on the immunobiology of cancer, with the study status listed as terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neoplasms

Snippet

Sponsor: Stanford University | Conditions: Neoplasms | Status: TERMINATED